Dylan Cozad joined the MJ team as director of analytics in our Risk Management + Commercial Insurance department. Dylan leads the data integration and standardization efforts for a wide range of datasets, as well as the creation and delivery of insightful reports for MJ’s Risk Management and Commercial Insurance clients, utilizing MJ’s proprietary analytics platform, APERTURE®.
Prior to MJ, Dylan gained professional experience for nearly a decade in the insurance industry. Dylan leads the analytics team in developing best practices for managing and analyzing loss, exposure, and policy data. Their work provides a comprehensive view of historical trends, forecasts future developments, and recommends solutions tailored to meet the risk management needs of MJ’s clients. Dylan’s data-driven mindset and forward thinking approach make him an invaluable asset to both MJ and our clients.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
The Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
For years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Volatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
On Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
The U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More